原研药港生物制药（沈阳）股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
158
NMPA:158
Drug Approvals
Lomefloxacin Aspartate Injection
- Product Name
- 门冬氨酸洛美沙星注射液
- Approval Number
- 国药准字H20064994
- Approval Date
- Jan 5, 2023
NMPA
Alprostadil for Injection
- Product Name
- 注射用前列地尔
- Approval Number
- 国药准字H20066831
- Approval Date
- Jan 5, 2023
NMPA
Potassium Sodium Dehydrographolide Succinate
- Product Name
- 炎琥宁
- Approval Number
- 国药准字H20067285
- Approval Date
- Feb 17, 2022
NMPA
Tripelennamine Hydrochloride Tablets
- Product Name
- 盐酸曲吡那敏片
- Approval Number
- 国药准字H21023461
- Approval Date
- Aug 18, 2021
NMPA
Benactyzine Hydrochloride Tablets
- Product Name
- 盐酸贝那替嗪片
- Approval Number
- 国药准字H21024407
- Approval Date
- Aug 18, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
Clinical Trials
No trials found
News
No news found